lisocabtagen maraleucel

Spain

Drugs containing this active substance

  • BREYANZI 1.1-70 × 10E6 CELLS/ML / 1.1-70 × 10E6 CELLS/ML DISPERSION FOR INFUSION

    It is used to treat adults with certain types of lymphoma (a blood cancer that affects the lymphatic tissue), including diffuse large B-cell lymphoma, high-grade B-cell lymphoma, primary mediastinal large B-cell lymphoma, follicular lymphoma, and mantle cell lymphoma.

    Form: solution for injection

    Active substance Dosage
    lisocabtagen maraleucel 1,1-70 × 10e6 CELULAS

    ATC: L01X L01XL L01XL08

    Manufacturer: Bristol-Myers Squibb Pharma Eeig